Lee Jennifer Kayden
SEC insider (Form 3/4/5 filer). CIK 0001801372. EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM). 34 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in BOSTON, MA.
Companies Lee Jennifer Kayden has filed insider reports for
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Officer, EVP, Head of North America
Lee Jennifer Kayden
CIK: 0001801372
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RHYTHM PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect75.8K shares at avg. $117.38$8.9M - Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect35K shares at avg. $24.29$850K - Aug 13, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect21.6K shares at avg. $6.80$147K - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Options (Right to Buy)
32.5K shares- - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
21.7K shares- - Feb 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
Tax PaymentDirect9.2K shares at avg. $108.99$1.0M - Feb 1, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect22.6K shares- - Feb 19, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect2K shares at avg. $57.22$116K - Feb 16, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect5.5K shares- - Feb 14, 2025RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
36.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 75,834 | $117.38 | $8,901,531 | Direct |
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 35,000 | $24.29 | $850,150 | Direct |
| Aug 13, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 21,601 | $6.80 | $146,887 | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Options (Right to Buy) | 32,500 | - | - | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 21,650 | - | - | Direct |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Tax Payment | 9,237 | $108.99 | $1,006,741 | Direct |
| Feb 1, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 22,612 | - | $0 | Direct |
| Feb 19, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 2,035 | $57.22 | $116,443 | Direct |
| Feb 16, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 5,500 | - | - | Direct |
| Feb 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 36,650 | - | - | Direct |
1-10 of 34 transactions